{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:31:56Z","timestamp":1792783916152,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea","award":["NRF- 2017R1D1A1A02019212"],"award-info":[{"award-number":["NRF- 2017R1D1A1A02019212"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Bio & Medical Technology Development Program of the NRF funded by the Korean government, the Ministry of Science, ICT & Future Planning","award":["NRF-2016M3A9B4919711"],"award-info":[{"award-number":["NRF-2016M3A9B4919711"]}],"id":[{"id":"https:\/\/ror.org\/032e49973","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hanmi Pharmaceutical Co., Ltd., Seoul, Republic of Korea."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11010-019-03542-7","type":"journal-article","created":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T22:02:30Z","timestamp":1555884150000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Co-treatment with interferon-\u03b3 and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis"],"prefix":"10.1007","volume":"458","author":[{"given":"Jun-Won","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Jong","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Su","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-6490","authenticated-orcid":false,"given":"Young Woo","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Woo","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Gyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"3542_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119:91\u2013112. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577","journal-title":"Circ Res"},{"key":"3542_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC (2016) Cardiac fibrosis: the fibroblast awakens. Circ Res 118:1021\u20131040. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306565","journal-title":"Circ Res"},{"key":"3542_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40824-016-0060-8","volume":"20","author":"Z Fan","year":"2016","unstructured":"Fan Z, Guan J (2016) Antifibrotic therapies to control cardiac fibrosis. Biomater Res 20:13. \n                    https:\/\/doi.org\/10.1186\/s40824-016-0060-8","journal-title":"Biomater Res"},{"key":"3542_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12265-012-9406-3","volume":"5","author":"M Dobaczewski","year":"2012","unstructured":"Dobaczewski M, De Haan JJ, Frangogiannis NG (2012) The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res 5:837\u2013847. \n                    https:\/\/doi.org\/10.1007\/s12265-012-9406-3","journal-title":"J Cardiovasc Transl Res"},{"key":"3542_CR5","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.jacc.2011.06.058","volume":"58","author":"A Gonz\u00e1lez","year":"2011","unstructured":"Gonz\u00e1lez A, Ravassa S, Beaumont J, L\u00f3pez B, D\u00edez J (2011) New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58:1833\u20131843. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.06.058","journal-title":"J Am Coll Cardiol"},{"key":"3542_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","volume":"7","author":"SW Borne Van Den","year":"2010","unstructured":"Van Den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7:30\u201337. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2009.199","journal-title":"Nat Rev Cardiol"},{"key":"3542_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jtcvs.2011.09.032","volume":"143","author":"WM Yarbrough","year":"2012","unstructured":"Yarbrough WM, Mukherjee R, Stroud RE, Rivers WT, Oelsen JM, Dixon JA, Eckhouse SR, Ikonomidis JS, Zile MR, Spinale FG (2012) Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature. J Thorac Cardiovasc Surg 143:215\u2013223. \n                    https:\/\/doi.org\/10.1016\/j.jtcvs.2011.09.032","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3542_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71:549\u2013574. \n                    https:\/\/doi.org\/10.1007\/s00018-013-1349-6","journal-title":"Cell Mol Life Sci"},{"key":"3542_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/B:HREV.0000011392.03037.7e","volume":"9","author":"JS Janicki","year":"2004","unstructured":"Janicki JS, Brower GL, Gardner JD, Chancey AL, Stewart JA (2004) The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling. Heart Fail Rev 9:33\u201342. \n                    https:\/\/doi.org\/10.1023\/B:HREV.0000011392.03037.7e","journal-title":"Heart Fail Rev"},{"key":"3542_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/CIRCRESAHA.112.266882","volume":"112","author":"FG Spinale","year":"2013","unstructured":"Spinale FG, Janicki JS, Zile MR (2013) Membrane-associated matrix proteolysis and heart failure. Circ Res 112:195\u2013208. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.266882","journal-title":"Circ Res"},{"issue":"1","key":"3542_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1023\/B:HREV.0000011394.34355.bb","volume":"9","author":"T Tsuruda","year":"2004","unstructured":"Tsuruda T, Costello-Boerrigter LC, Burnett JC (2004) Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev 9(1):53\u201361. \n                    https:\/\/doi.org\/10.1023\/B:HREV.0000011394.34355.bb","journal-title":"Heart Fail Rev"},{"key":"3542_CR12","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","volume":"116","author":"A Leask","year":"2015","unstructured":"Leask A (2015) Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res 116:1269\u20131276. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305381","journal-title":"Circ Res"},{"key":"3542_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227\u2013264. \n                    https:\/\/doi.org\/10.1146\/annurev.biochem.67.1.227","journal-title":"Annu Rev Biochem"},{"key":"3542_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3892\/ijmm.2017.3043","volume":"40","author":"JE Oh","year":"2017","unstructured":"Oh JE, Shim KY, Lee JI, Choi SI, Baik SK, Eom YW (2017) 1-Methyl-l-tryptophan promotes the apoptosis of hepatic stellate cells arrested by interferon-\u03b3 by increasing the expression of IFN-\u03b3R\u03b2, IRF-1 and FAS. Int J Mol Med 40:576\u2013582. \n                    https:\/\/doi.org\/10.3892\/ijmm.2017.3043","journal-title":"Int J Mol Med"},{"key":"3542_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1006\/scbi.2000.0315","volume":"10","author":"EC Borden","year":"2000","unstructured":"Borden EC, Lindner D, Dreicer R, Hussein M, Peereboom D (2000) Second-generation interferons for cancer: clinical targets. Semin Cancer Biol 10:125\u2013144. \n                    https:\/\/doi.org\/10.1006\/scbi.2000.0315","journal-title":"Semin Cancer Biol"},{"key":"3542_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1126\/science.1902591","volume":"252","author":"SE Ealick","year":"1991","unstructured":"Ealick SE, Cook WJ, Vijay-Kumar S, Carson M, Nagabhushan TL, Trotta PP, Bugg CE (1991) Three-dimensional structure of recombinant human interferon-gamma. Science 252:698\u2013702","journal-title":"Science"},{"key":"3542_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375\u2013386. \n                    https:\/\/doi.org\/10.1038\/nri1604","journal-title":"Nat Rev Immunol"},{"key":"3542_CR18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.humimm.2014.09.015","volume":"75","author":"L Dou","year":"2014","unstructured":"Dou L, Liang HF, Geller DA, Chen YF, Chen XP (2014) The regulation role of interferon regulatory factor-1 gene and clinical relevance. Hum Immunol 75:1110\u20131114. \n                    https:\/\/doi.org\/10.1016\/j.humimm.2014.09.015","journal-title":"Hum Immunol"},{"key":"3542_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ijc.10956","volume":"104","author":"Y Tomita","year":"2003","unstructured":"Tomita Y, Bilim V, Hara N, Kasahara T, Takahashi K (2003) Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells. Int J Cancer 104:400\u2013408. \n                    https:\/\/doi.org\/10.1002\/ijc.10956","journal-title":"Int J Cancer"},{"key":"3542_CR20","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/17826","volume":"397","author":"L Ulloa","year":"1999","unstructured":"Ulloa L, Doody J, Massagu\u00e9 J (1999) Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway. Nature 397:710\u2013713. \n                    https:\/\/doi.org\/10.1038\/17826","journal-title":"Nature"},{"key":"3542_CR21","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1074\/jbc.M004709200","volume":"276","author":"AK Ghosh","year":"2001","unstructured":"Ghosh AK, Yuan W, Mori Y, Chen SJ, Varga J (2001) Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300\/CBP transcriptional coactivators. J Biol Chem 276:11041\u201311048. \n                    https:\/\/doi.org\/10.1074\/jbc.M004709200","journal-title":"J Biol Chem"},{"key":"3542_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jhep.2006.09.014","volume":"46","author":"H Weng","year":"2007","unstructured":"Weng H, Mertens PR, Gressner AM, Dooley S (2007) IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads. J Hepatol 46:295\u2013303. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2006.09.014","journal-title":"J Hepatol"},{"key":"3542_CR23","doi-asserted-by":"publisher","first-page":"43470","DOI":"10.1074\/jbc.M302339200","volume":"278","author":"K Higashi","year":"2003","unstructured":"Higashi K, Inagaki Y, Fujimori K, Nakao A, Kaneko H, Nakatsuka I (2003) Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J Biol Chem 278:43470\u201343479. \n                    https:\/\/doi.org\/10.1074\/jbc.M302339200","journal-title":"J Biol Chem"},{"key":"3542_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.gastro.2005.03.088","volume":"129","author":"Y Inagaki","year":"2005","unstructured":"Inagaki Y, Kushida M, Higashi K, Itoh J, Higashiyama R, Hong YY, Kawada N, Namikawa K, Kiyama H, Bou-Gharios G, Watanabe T (2005) Cell type-specific intervention of transforming growth factor beta\/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 129:259\u2013268. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2005.03.088","journal-title":"Gastroenterology"},{"key":"3542_CR25","first-page":"1479","volume":"25","author":"L Gu","year":"2004","unstructured":"Gu L, Zhu YJ, Guo ZJ, Xu XX, Xu WB (2004) Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation. Acta Pharmacol Sin 25:1479\u20131488","journal-title":"Acta Pharmacol Sin"},{"key":"3542_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0923-1811(03)00044-6","volume":"32","author":"T Hasegawa","year":"2003","unstructured":"Hasegawa T, Nakao A, Sumiyoshi K, Tsuboi R, Ogawa H (2003) IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts. J Dermatol Sci 32:19\u201324. \n                    https:\/\/doi.org\/10.1016\/S0923-1811(03)00044-6","journal-title":"J Dermatol Sci"},{"key":"3542_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1096\/fj.14-258459","volume":"29","author":"F Poosti","year":"2014","unstructured":"Poosti F, Bansal R, Yazdani S, Prakash J, Post E, Klok P, van den Born J, de Borst MH, van Goor H, Poelstra K, Hillebrands JL (2014) Selective delivery of IFN-gamma to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis. FASEB J 29:1029\u20131042. \n                    https:\/\/doi.org\/10.1096\/fj.14-258459","journal-title":"FASEB J"},{"key":"3542_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.urology.2010.10.015","volume":"77","author":"Y Yao","year":"2011","unstructured":"Yao Y, Zhang J, Tan DQ, Chen XY, Ye DF, Peng JP, Li JT, Zheng YQ, Fang L, Li YK, Fan MX (2011) Interferon-gamma improves renal interstitial fibrosis and decreases intrarenal vascular resistance of hydronephrosis in an animal model. Urology 77:761. \n                    https:\/\/doi.org\/10.1016\/j.urology.2010.10.015","journal-title":"Urology"},{"key":"3542_CR29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1172\/JCI113998","volume":"83","author":"SJ Warner","year":"1989","unstructured":"Warner SJ, Friedman GB, Libby P (1989) Immune interferon inhibits proliferation and induces 2\u2032-5\u2032-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J Clin Invest 83:1174\u20131182. \n                    https:\/\/doi.org\/10.1172\/JCI113998","journal-title":"J Clin Invest"},{"key":"3542_CR30","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.170.5.1595","volume":"170","author":"GK Hansson","year":"1989","unstructured":"Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G (1989) Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med 170:1595\u20131608. \n                    https:\/\/doi.org\/10.1084\/jem.170.5.1595","journal-title":"J Exp Med"},{"key":"3542_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1172\/JCI118058","volume":"96","author":"J Varga","year":"1995","unstructured":"Varga J, Yufit T, Brown RR (1995) Inhibition of collagenase and stromelysin gene expression by interferon-gamma in human dermal fibroblasts is mediated in part via induction of tryptophan degradation. J Clin Invest 96:475\u2013481. \n                    https:\/\/doi.org\/10.1172\/JCI118058","journal-title":"J Clin Invest"},{"key":"3542_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-291X(90)91666-G","volume":"168","author":"W Dai","year":"1990","unstructured":"Dai W, Gupta SL (1990) Molecular cloning, sequencing and expression of human interferon-gamma-inducible indoleamine 2,3-dioxygenase cDNA. Biochem Biophys Res Commun 168:1\u20138. \n                    https:\/\/doi.org\/10.1016\/0006-291X(90)91666-G","journal-title":"Biochem Biophys Res Commun"},{"key":"3542_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fimmu.2014.00585","volume":"5","author":"GC Prendergast","year":"2014","unstructured":"Prendergast GC, Metz R, Muller AJ, Merlo LM, Mandik-Nayak L (2014) IDO2 in immunomodulation and autoimmune disease. Front Immunol 5:585. \n                    https:\/\/doi.org\/10.3389\/fimmu.2014.00585","journal-title":"Front Immunol"},{"key":"3542_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri1457","volume":"4","author":"AL Mellor","year":"2004","unstructured":"Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762\u2013774. \n                    https:\/\/doi.org\/10.1038\/nri1457","journal-title":"Nat Rev Immunol"},{"key":"3542_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cvr\/cvu062","volume":"102","author":"S Linthout Van","year":"2014","unstructured":"Van Linthout S, Miteva K, Tsch\u00f6pe C (2014) Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 102:258\u2013269. \n                    https:\/\/doi.org\/10.1093\/cvr\/cvu062","journal-title":"Cardiovasc Res"},{"key":"3542_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10741-013-9393-8","volume":"19","author":"SP Levick","year":"2014","unstructured":"Levick SP, Goldspink PH (2014) Could interferon-gamma be a therapeutic target for treating heart failure? Heart Fail Rev 19:227\u2013236. \n                    https:\/\/doi.org\/10.1007\/s10741-013-9393-8","journal-title":"Heart Fail Rev"},{"key":"3542_CR37","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.1073\/pnas.86.18.7144","volume":"86","author":"GS Feng","year":"1989","unstructured":"Feng GS, Taylor MW (1989) Interferon gamma-resistant mutants are defective in the induction of indoleamine 2,3-dioxygenase. Proc Natl Acad Sci USA 86:7144\u20137148. \n                    https:\/\/doi.org\/10.1073\/pnas.86.18.7144","journal-title":"Proc Natl Acad Sci USA"},{"key":"3542_CR38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1440-1711.2005.01372.x","volume":"83","author":"NL Webster","year":"2005","unstructured":"Webster NL, Wee J, Uren SJ, Boyle W, Sandrin MS (2005) Production and purification of human indoleamine 2,3-dioxygenase (HuIDO) protein in a baculovirus expression system and production and characterization of egg yolk antibody against the purified HuIDO. Immunol Cell Biol 83:542\u2013548. \n                    https:\/\/doi.org\/10.1111\/j.1440-1711.2005.01372.x","journal-title":"Immunol Cell Biol"},{"key":"3542_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC (2013) Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10:15\u201326. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2012.158","journal-title":"Nat Rev Cardiol"},{"key":"3542_CR40","doi-asserted-by":"publisher","first-page":"ZC14","DOI":"10.7860\/JCDR\/2014\/7820.4231","volume":"8","author":"B Rao","year":"2014","unstructured":"Rao B, Malathi N, Narashiman S, Rajan ST (2014) Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma. J Clin Diagn Res 8:ZC14. \n                    https:\/\/doi.org\/10.7860\/JCDR\/2014\/7820.4231","journal-title":"J Clin Diagn Res"},{"key":"3542_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2353\/ajpath.2007.060906","volume":"171","author":"K Reifenberg","year":"2007","unstructured":"Reifenberg K, Lehr HA, Torzewski M, Steige G, Wiese E, K\u00fcpper I, Becker C, Ott S, Nusser P, Yamamura KI, Rechtsteiner G (2007) Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 171:463\u2013472. \n                    https:\/\/doi.org\/10.2353\/ajpath.2007.060906","journal-title":"Am J Pathol"},{"key":"3542_CR42","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.112.199265","volume":"60","author":"L Mark\u00f3","year":"2012","unstructured":"Mark\u00f3 L, Kvakan H, Park JK, Qadri F, Spallek B, Binger KJ, Bowman EP, Kleinewietfeld M, Fokuhl V, Dechend R, M\u00fcller D (2012) Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 60:1430\u20131436. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.199265","journal-title":"Hypertension"},{"key":"3542_CR43","doi-asserted-by":"publisher","first-page":"e35506","DOI":"10.1371\/journal.pone.0035506","volume":"7","author":"YL Han","year":"2012","unstructured":"Han YL, Li YL, Jia LX, Cheng JZ, Qi YF, Zhang HJ, Du J (2012) Reciprocal interaction between macrophages and T cells stimulates IFN-gamma and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis. PLoS ONE 7:e35506. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035506","journal-title":"PLoS ONE"},{"key":"3542_CR44","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0002-9440(10)63241-5","volume":"165","author":"D Fairweather","year":"2004","unstructured":"Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Njoku DB, Rose NR (2004) Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol 165:1883\u20131894. \n                    https:\/\/doi.org\/10.1016\/S0002-9440(10)63241-5","journal-title":"Am J Pathol"},{"key":"3542_CR45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1073\/pnas.0408241102","volume":"102","author":"M Afanasyeva","year":"2005","unstructured":"Afanasyeva M, Georgakopoulos D, Belardi DF, Bedja D, Fairweather D, Wang Y, Kaya Z, Gabrielson KL, Rodriguez ER, Caturegli P, Kass DA (2005) Impaired up-regulation of CD25 on CD4\u2009+\u2009T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci USA 102:180\u2013185. \n                    https:\/\/doi.org\/10.1073\/pnas.0408241102","journal-title":"Proc Natl Acad Sci USA"},{"key":"3542_CR46","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1096\/fasebj.5.11.1907934","volume":"5","author":"MW Taylor","year":"1991","unstructured":"Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516\u20132522. \n                    https:\/\/doi.org\/10.1096\/fasebj.5.11.1907934","journal-title":"FASEB J"},{"key":"3542_CR47","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1172\/JCI31178","volume":"117","author":"DH Munn","year":"2007","unstructured":"Munn DH, Mellor AL (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147\u20131154. \n                    https:\/\/doi.org\/10.1172\/JCI31178","journal-title":"J Clin Invest"},{"key":"3542_CR48","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-014-1549-4","volume":"63","author":"GC Prendergast","year":"2014","unstructured":"Prendergast GC, Smith C, Thomas S, Mandik-Nayak L, Laury-Kleintop L, Metz R, Muller AJ (2014) Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer. Cancer Immunol Immunother 63:721\u2013735. \n                    https:\/\/doi.org\/10.1007\/s00262-014-1549-4","journal-title":"Cancer Immunol Immunother"},{"key":"3542_CR49","doi-asserted-by":"publisher","first-page":"e14698","DOI":"10.1371\/journal.pone.0014698","volume":"6","author":"J Croitoru-Lamoury","year":"2011","unstructured":"Croitoru-Lamoury J, Lamoury FM, Caristo M, Suzuki K, Walker D, Takikawa O, Taylor R, Brew BJ (2011) Interferon-gamma regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS ONE 6:e14698. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0014698","journal-title":"PLoS ONE"},{"key":"3542_CR50","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","volume":"196","author":"G Frumento","year":"2002","unstructured":"Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196:459\u2013468. \n                    https:\/\/doi.org\/10.1084\/jem.20020121","journal-title":"J Exp Med"},{"key":"3542_CR51","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.4049\/jimmunol.164.7.3512","volume":"164","author":"WA Chow","year":"2000","unstructured":"Chow WA, Fang JJ, Yee JK (2000) The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J Immunol 164:3512\u20133518. \n                    https:\/\/doi.org\/10.4049\/jimmunol.164.7.3512","journal-title":"J Immunol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03542-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03542-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T19:15:56Z","timestamp":1587410156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03542-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3542"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03542-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}